BridgeMD
New treatment option for Asphyxia Neonatorum
Official title Sustained Cord Circulation at Emergency Cesarean Section
ClinicalTrials.gov ID: NCT06540222
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate if sustained cord circulation during resuscitation improves outcomes for term neonates born by emergency Cesarean section. The main question it aims to answer is: Does sustained cord circulation reduce admission rates to neonatal care?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 37 to 42
You may be able to join if
- Singleton neonate
- Born alive
- Gestational age ≥37 weeks
- Born by emergency cesarean section, epidural/spinal anesthesia, where the pediatric/neonatal team has been called for to attend.
You likely can't join if
- Major congenital malformation that may affect resuscitation or outcome measures.
- Major genetic disorder that may affect resuscitation or outcome measures.
The study team makes the final eligibility decision.
Where it's taking place
- Gothenburg, Sweden
- Halmstad, Sweden
- Linköping, Sweden
- Lund, Sweden
- Malmö, Sweden
- Örebro, Sweden
- Stockholm, Sweden
- Umeå, Sweden
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 37 weeks to 42 weeks. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Gothenburg, Sweden; Halmstad, Sweden; Linköping, Sweden; Lund, Sweden; Malmö, Sweden; Örebro, Sweden and 2 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.